Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
1.560
0.00 (0.00%)
Jul 21, 2026, 12:02 PM EDT - Market open
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $156.64 million as of July 21, 2026. Its market cap has decreased by -48.86% in one year.
Market Cap
156.64M
Enterprise Value
168.22M
1-Year Change
-48.86%
Ranking
Category
Stock Price
$1.56
ChartMarket Cap Chart
Since the IPO on July 2, 2021, Nyxoah's market cap has decreased from $746.03M to $156.64M, a decrease of -79.00%. That is a compound annual growth rate of -26.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 156.64M | -24.09% |
| Dec 31, 2025 | 206.37M | -35.52% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | -26.92% |
| Jul 2, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anbio Biotechnology | 417.84M |
| OraSure Technologies | 265.07M |
| Sanara MedTech | 229.10M |
| Utah Medical Products | 220.65M |
| Embecta | 204.09M |
| KORU Medical Systems | 186.49M |
| Pro-Dex | 174.52M |
| Stereotaxis | 146.90M |